Improvements in the bioanalytical method performance for steroid phosphates using a hybrid surface barrier to minimize analyte-metal surface interactions

Significance of the Topic

Phosphorylated steroids are prone to adsorption on metal surfaces in conventional liquid chromatography systems, leading to poor peak shapes, reduced sensitivity, and variable reproducibility. Addressing these challenges is critical in bioanalytical applications where accurate quantification at low concentrations is required for pharmacokinetic and drug metabolism studies.

Study Objectives and Overview

This study evaluated the performance of a hybrid inert surface technology in a UPLC flow path to minimize analyte–metal interactions. The focus was on two steroid phosphate drugs, hydrocortisone phosphate and dexamethasone phosphate, comparing the novel Acquity Premier system against standard hardware.

Methodology and Instrumentation

The bioanalytical method employed the following configuration:

• LC System: ACQUITY Premier UPLC
• Detector: Xevo TQ-XS triple quadrupole
• Column: 2.1×50 mm ACQUITY MaxPeak HSS T3, 1.8 µm particle size, operating at 60 °C
• Mobile Phases: A – 0.1% formic acid in water; B – 0.1% formic acid in acetonitrile
• Gradient: 5% to 75% B over 2.5 minutes
• Flow Rate: 600 µL/min; Injection Volume: 10 µL; Sample Temperature: 5 °C
• Analytes monitored by MRM transitions (hydrocortisone phosphate m/z 443.19→327.15; dexamethasone phosphate m/z 473.32→435.16)

Key Results and Discussion

Implementing the inert hybrid surface in the Premier system resulted in markedly improved chromatographic performance:

• Sensitivity gains of 10-fold for hydrocortisone phosphate and 7.5-fold for dexamethasone phosphate, compared to standard hardware
• Lower limits of quantification achieved: 5 ng/mL for hydrocortisone phosphate (vs higher in standard system) and 1 ng/mL for dexamethasone phosphate
• Calibration linear over 5–1000 ng/mL (hydrocortisone phosphate) and 1–1000 ng/mL (dexamethasone phosphate) with R2 > 0.99
• Assay precision <11% (hydrocortisone phosphate) and <8% (dexamethasone phosphate) across LLOQ, LQC, MQC and HQC; accuracies ranged from 92.6% to 111% across quality control levels

Benefits and Practical Applications of the Method

The enhanced inert flow path delivers reliable low-level quantification of metal-sensitive compounds. Reduced method development time, improved peak shapes, and consistent assay performance support applications in bioanalysis for drug discovery, pharmacokinetic profiling, and therapeutic drug monitoring.

Future Trends and Opportunities

As analytical demands expand to include highly polar, labile, and metal-binding species, inert-surface technologies will become more widely adopted. Future developments may extend to large biomolecules, peptide phosphates, and coupling with high-resolution mass spectrometry. Integration of this approach in routine platforms could streamline workflows in pharmaceutical, clinical, and environmental laboratories.

Conclusion

Adopting a hybrid inert surface in UPLC systems effectively mitigates analyte–metal interactions, leading to superior sensitivity, reproducibility, and throughput for steroid phosphate bioanalysis compared to conventional hardware.

Reference

• Tanna N, Plumb R. Improvements in the bioanalytical method performance for steroid phosphates using a hybrid surface barrier to minimize analyte-metal surface interactions. Waters Corporation, 2021.